Intuitive Surgical Downgraded as Analysts Trim Targets

Intuitive Surgical was the sharpest move in Friday's analyst activity. The robotic surgery giant was downgraded, with one buy rating shifting to a hold. The consensus target price slipped to $478.30 from $477.63. At a $157 billion market cap, even small shifts in analyst sentiment carry weight.

McCormick also drew attention. Analysts cut their average target to $54.46 from $54.85. The ORTEX Index Rebalance Radar puts McCormick at a 77% probability of deletion from the MSCI World index in the November review, with $735 million of forced selling expected. That overhang could keep pressure on the stock through the 11 November announcement.

Bloom Energy saw multiple analyst changes simultaneously, a rare occurrence. The consensus buy count edged down from two to one, while the target price held near $284.77. The energy firm carries 6.9% short interest as a percentage of free float.

Moderna saw its average target trimmed to $135.05. The biotech holds a $135 average target across 22 analysts, with 15 holds and four sells in the mix.

CrowdStrike was the outlier on the upside. Its target price moved to $247.25, the only notable upward target revision in the batch. Cybersecurity remains a sector where analysts hold their ground.